Generic Specialty Group is an independent pharmaceutical API sourcing partner delivering a Complete Source Quote — CoA, USDMF/CEP, impurity profile, pricing, and lead time — within 24 hours of every inquiry.
✓ FDA · EMA · Health Canada inspected sources · ✓ ICH Q7 GMP · ✓ USDMF status confirmed at quote
Semaglutide data exclusivity expired Jan 2026. Download our 12-point checklist — GMP qualification, USDMF filing strategy, NDMA compliance, and lead time benchmarks.
Semaglutide, Tirzepatide, and Liraglutide are our highest-demand molecules in 2026. USDMF on file. Competitive pricing. Samples available.
View all 16 GLP-1 / Diabetes APIs →| Molecule | Class | Regulatory ⓘ | Purity | MOQ |
|---|
Generic Specialty Group is headquartered in Vancouver, British Columbia — an independent API sourcing partner with no manufacturing facility and no captive supply to push.
Our sole focus is identifying the best GMP-qualified source for your molecule, market, and regulatory requirements — then delivering a complete dossier in 24 hours. We work with manufacturers in India, China, Europe, and North America.
Part of the Burrard Pharma group.
Name the molecule, quantity, and target market. Attach specs if available. Under 2 minutes.
Identify the best GMP-certified source for your market, quantity, and regulatory requirements.
CoA, USDMF/CEP status, impurity profile, stability data, pricing, MOQ, and lead time — one document.
Move to sample shipment or commercial order. We coordinate QA, logistics, and customs end-to-end.
We don't send a price list. Every Complete Source Quote is a full regulatory package — because your QA team needs documentation before procurement proceeds.
Pharmacopoeial Standards
Nitrosamine Notice
All high-risk molecules (sartans, metformin, ranitidine class) include FDA/EMA nitrosamine risk assessment and NDMA confirmatory test results as standard.
Not a price list — a full regulatory dossier: CoA, DMF status, impurity profile, stability data, and pricing. Every time.
No manufacturing facility to push. We source from the best-qualified GMP manufacturer for your market and requirements.
Our listed 170+ molecules are active inquiries. We can source virtually any approved generic API globally.
FDA, EMA, Health Canada, TGA — we match source to market automatically, every inquiry.
OEB4/5 oncology APIs with full containment docs — PPE specs, engineering controls, handling SOPs — as standard.
Part of Burrard Pharma group: established supplier relationships, audit history, and regulatory partnerships.
The Complete Source Quote arrived in under 18 hours with a full USDMF reference letter and ICH Q3A impurity profile — exactly what our QA team needed to move to procurement.
We sourced semaglutide and liraglutide from GSG for our compounding programme. The CEP status and NDMA documentation were included without us even asking. Highly recommended.
For our paclitaxel HPAPI programme, GSG delivered full OEB4 containment documentation and GMP certificates within the SLA. Competitive pricing and no surprises at customs.
Testimonials represent anonymised feedback from verified B2B clients. Company names withheld by request.
Can't find the answer? Email us at [email protected] — we respond within one business day.
Submit a molecule inquiry and receive a full regulatory and commercial package — CoA, USDMF/CEP reference, impurity profile, pricing, and lead time — within 24 business hours. Every time.
Request a Quote →Submit your molecule and requirements. We respond with a complete regulatory and commercial package within one business day.
Complete Source Quote · 24-hour SLA